QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

GKOS

QT67Glaukos Corporation
NYSE·Healthcare·Medical - Devices·USA
Latest market price
130.68
+3.27+2.57%
OverviewShort InterestFilings
GKOSQT67Glaukos Corporation·NYSE
OverviewShort InterestFilings
130.68+2.57%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-3.28
Insider Own3.17%
Shs Outstand58.73M
Perf Week5.17%
Market Cap7.48BForward P/E294.46EPS next Y0.44Insider Trans1.30%Shs Float-Perf Month-6.59%
Enterprise Value7.48BPEG0.34EPS next Q-0.21Inst Own-Short Float-Perf Quarter28.00%
Income-191572127.00P/S13.57EPS this Y84.33%Inst Trans-Short Ratio-Perf Half Y14.87%
Sales551.35MP/B11.02EPS next Y186.35%ROA-21.19%Short Interest-Perf YTD15.74%
Book/sh11.43P/C-EPS next 5Y-ROE-26.46%52W High148.11 -11.77%Perf Year30.93%
Cash/sh4.72P/FCF-EPS past 3/5Y-ROIC-10.40%52W Low73.16 78.62%Perf 3Y-
Dividend Est.-EV/EBITDA-51.96Sales past 3/5Y21.45% 17.64%Gross Margin78.08%Volatility2.68% 4.44%Perf 5Y-
Dividend TTM-EV/Sales13.57EPS Y/Y TTM68.95%Oper. Margin-15.58%ATR (14)6.63Perf 10Y-
Dividend Ex-Date-Quick Ratio4.73Sales Y/Y TTM44.13%Profit Margin-34.34%RSI (14)56.73Recom2.29
Dividend Gr. 3/5Y-Current Ratio5.43EPS Q/Q18.18%SMA208.64%Beta1.05Target Price151.25
Payout0.00%Debt/Eq0.15Sales Q/Q41.12%SMA503.79%Rel Volume0.99Prev Close127.41
Employees995LT Debt/Eq0.21EarningsJul 29SMA20021.22%Avg Volume993.31KPrice130.68
IPO DateJun 25, 2015Option/ShortYes / YesEPS/Sales Surpr.40.00% 10.22%Net Debt/EBITDA0.01Volume984,179Change2.57%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-17-26ReiteratedNeedhamBuy$136 → $150
May-21-26ReiteratedBTIGBuy$141 → $162
May-20-26ReiteratedBTIGBuy$141 → $162
Apr-30-26ReiteratedStifel NicolausHold$160 → $170
Apr-30-26ReiteratedBTIGBuy$131 → $141
Apr-30-26ReiteratedNeedhamBuy$127 → $136
Feb-18-26ReiteratedWells FargoOverweight$122 → $135
Feb-18-26ReiteratedNeedhamBuy$125 → $127
Jan-28-26ReiteratedBTIGBuy$116 → $131
Jan-22-26ReiteratedStifel NicolausHold$115 → $160
Latest News
Jun-17-26
Jun-17-2609:05AM
Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For WednesdayBenzinga
06:19AM
Needham Maintains Buy on Glaukos, Raises Price Target to $150Benzinga
Jun-11-26
Jun-11-2611:13AM
Citigroup Maintains Buy on Glaukos, Raises Price Target to $162Benzinga
Jun-10-26
Jun-10-2605:59AM
BTIG Reiterates Buy on Glaukos, Maintains $162 Price TargetBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue552507383
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A12111494
Gross Profit430393289
Selling, General and Administrative Excl. Other354329263
Research and Development163151136
Other Operating Expense-1013
Operating Income-86-87-122
Interest Expense4510
Unusual Expense
———
Non-Operating Income (Expense)10410213
Net Income Before Taxes-194-193-146
Income Taxes-6-51
Consolidated Net Income-190-188-146
Net Income From Continuing Operations-190-188-146
Net Income-190-188-146
EPS (Recurring)-3.28-3.28-2.77
EPS (Basic, Before Extraordinaries)-3.28-3.28-2.77
EPS (Diluted)-3.28-3.28-2.77
EBITDA-144-146-96
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio13.7312.69—
Gross Margin77.9077.5175.46
Operating Margin-15.58-17.16-31.85
Net Margin-34.42-37.08-38.12
Shares Outstanding585753
Market Capitalization7,5796,436—
Operating Lease Expense
———
Insider Trading Volume
$149.82$141.35$132.87$124.39$115.92● Close Price0.00M6.33M12.66M18.99M25.32MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Hoffmeister David FDirectorMay 26 '26Option Exercise24.6930,000740,70047,671May 28 12:00 AM
Kliman Gilbert HDirectorMay 14 '26Option Exercise24.6910,000246,90040,528May 18 12:00 AM
Kliman Gilbert HDirectorMay 14 '26Sale140.765,000703,80035,528May 18 12:00 AM
Kliman Gilbert HDirectorMay 11 '26Sale135.005,000675,00035,528May 13 12:00 AM
Kliman Gilbert HDirectorMay 11 '26Option Exercise24.6910,000246,90040,528May 13 12:00 AM
Gilliam Joseph EPRESIDENT & COOMay 01 '26Sale143.5419,5732,809,50873,419May 04 12:00 AM
WEN LEANADirectorMay 01 '26Sale143.351,700243,69519,739May 04 12:00 AM
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERApr 30 '26Option Exercise38.6820,000773,60053,681May 04 12:00 AM
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERApr 30 '26Sale140.0010,0001,400,00043,681May 04 12:00 AM
Navratil TomasCHIEF DEVELOPMENT OFFICERApr 10 '26Sale117.622,093246,17690,370Apr 14 12:00 AM
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERMar 25 '26Sale106.462,511267,32141,967Mar 27 12:00 AM
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERMar 24 '26Sale105.241,521160,07046,498Mar 25 12:00 AM
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICERMar 17 '26Sale99.1562561,96949,249Mar 19 12:00 AM
Navratil TomasCHIEF DEVELOPMENT OFFICERMar 16 '26Sale98.041,031101,07973,631Mar 19 12:00 AM
WEISNER AIMEE SDirectorFeb 19 '26Option Exercise24.6930,000740,70033,806Feb 23 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR